Innovative Immuno-Oncology Consortium

The organization’s mission is to expedite the development of immunotherapy products for cancer and other unmet medical needs. This includes basic science, translational and clinical research, treatment and education of cancer patients.

The organization was formed in 2025. Being the initial year, the organization was setting up its programs and did not yet have any active program services in place during the tax year.

Innovative Immuno-Oncology Consortium is a 501(c)(3) nonprofit (EIN 39-2445499) based in Santa Monica, CA.